Adenosine Checkpoint Pathway

The "Adenosine Checkpoint Pathway" is a regulatory immune checkpoint mechanism in which extracellular adenosine, generated in the tumor microenvironment, suppresses anti-tumor immune responses through engagement of adenosine receptors on immune cells, thereby distinguishing it from other checkpoint pathways by its reliance on adenosine-mediated signaling.

11

Publications

806

Citations

179

Authors

72

Institutions

Publications per year

2017–2026

10

Authors

179

  1. GG
    Ginna G. Laport

    Stanford University, United States

    1 publications · 339 citations

    1

    h-index

  2. II
    Ignacio I. Wistuba

    The University of Texas MD Anderson Cancer Center, United States

    1 publications · 26 citations

    1

    h-index

  3. PK
    Paulus Kristanto

    Université Libre de Bruxelles, Belgium

    1 publications · 27 citations

    1

    h-index

  4. PZ
    Pengfei Zhang

    University of California, Davis, United States

    1 publications · 172 citations

    1

    h-index

  5. JE
    Jenny Eklöf

    University of Gothenburg, Sweden

    1 publications · 72 citations

    1

    h-index

1–5 of 179

Venues

  1. Cancer Discovery

    2 publications · 355 citations

    2

    h-index

  2. Nature Communications

    1 publications · 27 citations

    1

    h-index

  3. Journal of Hematology & Oncology

    1 publications · 172 citations

    1

    h-index

  4. Frontiers in Oncology

    1 publications · 26 citations

    1

    h-index

  5. Journal for ImmunoTherapy of Cancer

    JITC · 1 publications · 14 citations

    1

    h-index

1–5